Peripheral Stent Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Peripheral Stent Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)


The global revenue from the Peripheral Stent Implants Market was approximately US$ 3.9 Billion in 2024. The market is anticipated to reach a valuation of approximately US$ 7.1 Billion by the end of 2031.

Factors Driving Global Market Growth:
• Rising Patient Base and Geriatric Population: The prevalence of peripheral artery disease (PAD) has been on the rise, driven by factors such as smoking, diabetes, and hypercholesterolemia, which are associated with cardiovascular diseases (CVD). This has created a growing patient base for peripheral stent implants.
• Favorable Reimbursement Policies: Favorable reimbursement policies for outpatient surgery have contributed to the market's growth. An increase in outpatient cases, particularly in developing nations, has further boosted demand for peripheral vascular devices.

Challenges Affecting Market Growth:
• Stringent Regulations: The production and use of peripheral stent implants are subject to strict regulations and lengthy approval processes by organizations like the FDA and CE Mark, which can limit market growth.
• Product Recalls: Instances of product recalls due to adverse health consequences, such as bleeding risks and strokes, have affected the market. These recalls can erode consumer confidence and hinder market expansion.
• Healthcare Costs and Public Awareness: While peripheral stent implants are more affordable than surgical procedures, hospitalization costs remain significant. Increasing public awareness of asymptomatic PAD and its early detection is essential, particularly in resource-limited nations.

Country-wise Insights:
• United States: The U.S. holds a dominant market share due to the high prevalence of PAD driven by factors like smoking, sedentary lifestyles, and a large geriatric population. Availability of drug-eluting stents and favorable medical reimbursement policies contribute to market growth.
• Germany: Germany is a lucrative market driven by product innovation, investment in advanced stents, and a rising prevalence of obesity. The market benefits from an increase in minimally invasive surgeries and percutaneous coronary intervention (PCI) procedures.
• China: China plays a significant role in manufacturing stent grafts and exporting products to neighboring countries. Advanced products, a high geriatric population, and product exports contribute to its prominence in the market.

Competitive Landscape:

Key players are focusing on expanding their sales and marketing investments globally, with a direct sales force, clinical specialists, distributors, and strategic partnerships. Collaboration with leading distributors and product development with groundbreaking advancements are central to their strategies.

Key Companies in the Market:
• Abbott Laboratories
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Medical, Inc.
• Cardinal Health, Inc.
• iVascular SLU
• Medtronic Plc.
• Terumo Corporation
• W. L. Gore & Associates Inc.

Key Segments Covered in Peripheral Stent Implants Industry Research

Product
• Bare Metal Stents (BMS)
• Covered Stents
• Drug Eluting Stents (DES)

Artery
• Carotid Artery Stents
• Fem-Pop Artery Stents
• Iliac Artery Stents
• Infrapop Artery Stents

End User
• Hospitals
• Ambulatory Surgical Centers/Outpatient

Region
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Please note: The PDF e-mail from publisher version of this report is for a global site license. The Delivery Timelines - 5 working days.


1. Executive Summary
1.1. Global Peripheral Stent Implants Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Production Output and Trade Statistics, 2018 – 2023
3.1. Global Peripheral Stent Implants Market Production Output, by Region, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa
4. Price Analysis, 2018 – 2023
4.1. Global Average Price Analysis, by Product/ Material, US$ Per Unit, 2018 – 2023
4.2. Prominent Factor Affecting Peripheral Stent Implants Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Peripheral Stent Implants Market Outlook, 2018 – 2031
5.1. Global Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
5.1.1. Key Highlights
5.1.1.1. Bare Metal Stents (BMS)
5.1.1.2. Covered Stents
5.1.1.3. Drug Eluting Stents (DES)
5.2. Global Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
5.2.1. Key Highlights
5.2.1.1. Carotid Artery Stents
5.2.1.2. Fem-Pop Artery Stents
5.2.1.3. Iliac Artery Stents
5.2.1.4. Infrapop Artery Stents
5.3. Global Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Ambulatory Surgical Centers/Outpatients
5.4. Global Peripheral Stent Implants Market Outlook, by Region, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
5.4.1. Key Highlights
5.4.1.1. North America
5.4.1.2. Europe
5.4.1.3. Asia Pacific
5.4.1.4. Latin America
5.4.1.5. Middle East & Africa
6. North America Peripheral Stent Implants Market Outlook, 2018 – 2031
6.1. North America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.1.1. Key Highlights
6.1.1.1. Bare Metal Stents (BMS)
6.1.1.2. Covered Stents
6.1.1.3. Drug Eluting Stents (DES)
6.2. North America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.2.1. Key Highlights
6.2.1.1. Carotid Artery Stents
6.2.1.2. Fem-Pop Artery Stents
6.2.1.3. Iliac Artery Stents
6.2.1.4. Infrapop Artery Stents
6.3. North America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Ambulatory Surgical Centers/Outpatients
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. North America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.1. Key Highlights
6.4.1.1. U.S. Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.1.2. U.S. Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.1.3. U.S. Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.1.4. Canada Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.1.5. Canada Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.1.6. Canada Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Europe Peripheral Stent Implants Market Outlook, 2018 – 2031
7.1. Europe Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.1.1. Key Highlights
7.1.1.1. Bare Metal Stents (BMS)
7.1.1.2. Covered Stents
7.1.1.3. Drug Eluting Stents (DES)
7.2. Europe Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.2.1. Key Highlights
7.2.1.1. Chemotherapy/ Oncology
7.2.1.2. Paediatrics/Neonatology
7.2.1.3. Analgesia
7.2.1.4. Hematology
7.3. Europe Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Ambulatory Surgical Centers/Outpatients
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Europe Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1. Key Highlights
7.4.1.1. Germany Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.2. Germany Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.3. Germany Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.4. U.K. Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.5. U.K. Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.6. U.K. Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.7. France Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.8. France Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.9. France Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.10. Italy Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.11. Italy Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.12. Italy Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.13. Turkey Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.14. Turkey Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.15. Turkey Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.16. Russia Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.17. Russia Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.18. Russia Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.19. Rest of Europe Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.20. Rest of Europe Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.1.21. Rest of Europe Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Asia Pacific Peripheral Stent Implants Market Outlook, 2018 – 2031
8.1. Asia Pacific Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.1.1. Key Highlights
8.1.1.1. Bare Metal Stents (BMS)
8.1.1.2. Covered Stents
8.1.1.3. Drug Eluting Stents (DES)
8.2. Asia Pacific Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.2.1. Key Highlights
8.2.1.1. Carotid Artery Stents
8.2.1.2. Fem-Pop Artery Stents
8.2.1.3. Iliac Artery Stents
8.2.1.4. Infrapop Artery Stents
8.3. Asia Pacific Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Ambulatory Surgical Centers/Outpatients
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Asia Pacific Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1. Key Highlights
8.4.1.1. China Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.2. China Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.3. China Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.4. Japan Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.5. Japan Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.6. Japan Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.7. South Korea Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.8. South Korea Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.9. South Korea Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.10. India Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.11. India Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.12. India Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.13. Southeast Asia Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.14. Southeast Asia Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.15. Southeast Asia Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.16. Rest of Asia Pacific Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.17. Rest of Asia Pacific Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.1.18. Rest of Asia Pacific Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Latin America Peripheral Stent Implants Market Outlook, 2018 – 2031
9.1. Latin America Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.1.1. Key Highlights
9.1.1.1. Bare Metal Stents (BMS)
9.1.1.2. Covered Stents
9.1.1.3. Drug Eluting Stents (DES)
9.2. Latin America Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.2.1.1. Carotid Artery Stents
9.2.1.2. Fem-Pop Artery Stents
9.2.1.3. Iliac Artery Stents
9.2.1.4. Infrapop Artery Stents
9.3. Latin America Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Ambulatory Surgical Centers/Outpatients
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Latin America Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1. Key Highlights
9.4.1.1. Brazil Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.2. Brazil Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.3. Brazil Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.4. Mexico Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.5. Mexico Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.6. Mexico Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.7. Argentina Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.8. Argentina Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.9. Argentina Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.10. Rest of Latin America Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.11. Rest of Latin America Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.1.12. Rest of Latin America Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Peripheral Stent Implants Market Outlook, 2018 – 2031
10.1. Middle East & Africa Peripheral Stent Implants Market Outlook, by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.1.1. Key Highlights
10.1.1.1. Bare Metal Stents (BMS)
10.1.1.2. Covered Stents
10.1.1.3. Drug Eluting Stents (DES)
10.2. Middle East & Africa Peripheral Stent Implants Market Outlook, by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.2.1. Key Highlights
10.2.1.1. Carotid Artery Stents
10.2.1.2. Fem-Pop Artery Stents
10.2.1.3. Iliac Artery Stents
10.2.1.4. Infrapop Artery Stents
10.3. Middle East & Africa Peripheral Stent Implants Market Outlook, by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.3.1. Key Highlights
10.3.1.1. Hospitals
10.3.1.2. Ambulatory Surgical Centers/Outpatients
10.3.2. BPS Analysis/Market Attractiveness Analysis
10.4. Middle East & Africa Peripheral Stent Implants Market Outlook, by Country, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1. Key Highlights
10.4.1.1. GCC Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.2. GCC Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.3. GCC Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.4. South Africa Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.5. South Africa Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.6. South Africa Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.7. Egypt Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.8. Egypt Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.9. Egypt Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.10. Nigeria Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.11. Nigeria Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.12. Nigeria Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.13. Rest of Middle East & Africa Peripheral Stent Implants Market by Product, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.14. Rest of Middle East & Africa Peripheral Stent Implants Market by Artery, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.1.15. Rest of Middle East & Africa Peripheral Stent Implants Market by End User, Value (US$ Bn) and Volume (‘000 Units), 2018 – 2031
10.4.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. By End User vs by Artery Heat map
11.2. Manufacturer vs by Artery Heatmap
11.3. Company Market Share Analysis, 2023
11.4. Competitive Dashboard
11.5. Company Profiles
11.5.1. Abbott Laboratories
11.5.1.1. Company Overview
11.5.1.2. Product Portfolio
11.5.1.3. Financial Overview
11.5.1.4. Business Strategies and Development
11.5.2. B. Braun Melsungen AG
11.5.2.1. Company Overview
11.5.2.2. Product Portfolio
11.5.2.3. Financial Overview
11.5.2.4. Business Strategies and Development
11.5.3. Biotronik SE & Co. KG
11.5.3.1. Company Overview
11.5.3.2. Product Portfolio
11.5.3.3. Financial Overview
11.5.3.4. Business Strategies and Development
11.5.4. Boston Scientific Corporation
11.5.4.1. Company Overview
11.5.4.2. Product Portfolio
11.5.4.3. Financial Overview
11.5.4.4. Business Strategies and Development
11.5.5. Cook Medical, Inc.
11.5.5.1. Company Overview
11.5.5.2. Product Portfolio
11.5.5.3. Financial Overview
11.5.5.4. Business Strategies and Development
11.5.6. Cardinal Health, Inc.
11.5.6.1. Company Overview
11.5.6.2. Product Portfolio
11.5.6.3. Financial Overview
11.5.6.4. Business Strategies and Development
11.5.7. iVascular SLU
11.5.7.1. Company Overview
11.5.7.2. Product Portfolio
11.5.7.3. Financial Overview
11.5.7.4. Business Strategies and Development
11.5.8. Medtronic Plc.
11.5.8.1. Company Overview
11.5.8.2. Product Portfolio
11.5.8.3. Financial Overview
11.5.8.4. Business Strategies and Development
11.5.9. Terumo Corporation
11.5.9.1. Company Overview
11.5.9.2. Product Portfolio
11.5.9.3. Financial Overview
11.5.9.4. Business Strategies and Development
11.5.10. W. L. Gore & Associates Inc.
11.5.10.1. Company Overview
11.5.10.2. Product Portfolio
11.5.10.3. Financial Overview
11.5.10.4. Business Strategies and Development
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings